ManageChatDiscover
425277

Expression of miR-181a1-3p and its Correlation with TGF-β1 and Chromogranin A in Patients with Type 1 Diabetes Mellitus

Article

Last updated: 04 May 2025

OverviewSimilar Items

Subjects

-

Tags

Clinical microbiology

Abstract

Background: Type 1 Diabetes (T1DM) is a prevalent chronic illness, especially in children and teenagers. This rising incidence indicates the necessity of effective control and research. It is Objective: This study is designed to investigate the role of MiR-181a-1-3p, TGF- β 1 and Chromogranin A(CgA) levels in the development of T1DM. Methodology: The control case study involved 120 participants, of whom 40 were apparently healthy controls group and 80 T1DM patients diagnosed by a specialist in the Diabetic Department / Al-sader Medical City in AL- Najaf Al-Ashraf province from October 2023 till the end of February 2024. Blood sample was collected from all participants to detect TGF- β 1 and CgA serum level by enzyme linked immunosorbent assay (ELISA) and MiR-181a-1-3-p by the reverse transcription polymerase chain reaction (RT-PCR). Results: On the other hand, the anti-GAD65 and C-peptide diagnosis was conducted by (automatid Snibe MAGLUMI X3). The results showed that serum TGF- β 1 was significant in the healthy controls (735.37±103.41), which is significantly higher than (322.54 ±69.72) ng/ml patients. Meanwhile, there was a marked increase in the serum level of CgA in T1DM patients compared to control groups (1260.21 ± 850.21; 439.47±202.05) ng /ml. The expression of MiR-181a-1-3p was significantly higher in the control group than the patients group. The serum level of anti-GAD antibodies among patients with T1DM was significantly higher than in healthy controls (P<0.001) (375.01; 5.66 U/ml). All patients showed decreased serum level of C-peptide compared healthy controls. Conclusions: Finally, both miRNA181a-1-3-p. and serum level of TGF- β 1 were considered prognosis marker in T1DM especially when corelated with Chromogranin A to detect disease progressive.

DOI

10.21608/ejmm.2025.372581.1548

Keywords

T1D, Chromogranin A, TGF- β 1, MiR-181a-1-3-p

Authors

First Name

Zaid

Last Name

Twayej

MiddleName

A.

Affiliation

Laboratory Department, Immunology and Serology Unit, Alfurat Al-awsat Hospital, Najaf, Iraq

Email

ztwyj77@gmail.com

City

najaf

Orcid

-

First Name

Mayyada

Last Name

Darweesh

MiddleName

F.

Affiliation

Department of Biology, Faculty of Science, University of Kufa, Najaf, Iraq

Email

mayyadafdarweesh2@yahoo.com

City

najaf

Orcid

-

Volume

34

Article Issue

4

Related Issue

54773

Issue Date

2025-10-01

Receive Date

2025-04-03

Publish Date

2025-10-01

Print ISSN

1110-2179

Online ISSN

2537-0979

Link

https://ejmm.journals.ekb.eg/article_425277.html

Detail API

http://journals.ekb.eg?_action=service&article_code=425277

Order

425,277

Type

New and original researches in the field of Microbiology.

Type Code

2,038

Publication Type

Journal

Publication Title

Egyptian Journal of Medical Microbiology

Publication Link

https://ejmm.journals.ekb.eg/

MainTitle

Expression of miR-181a1-3p and its Correlation with TGF-β1 and Chromogranin A in Patients with Type 1 Diabetes Mellitus

Details

Type

Article

Created At

04 May 2025